Insights from Matilde Thye Kveiborg, Director of Medical Writing and Tanja Jensen, Senior Medical Writer

Rare diseases are often multifaceted, and a single endpoint is often not sufficient to fully describe treatment

At the bottom of the EBM hierarchy, mechanistic evidence is not highly valued by the HTA bodies responsible for…

Lionel RIOU FRANÇA, Chief Scientific Officer, was involved in two analyses involving patients with Late-Onset Pompe…

Cell and gene therapies are multiplying, and with them the hopes of patients, their families, and healthcare professionals…

Scale your clinical development teams with Aixial’s FSP models, providing biometrics expertise, governance, and operational flexibility.

Transform clinical data into actionable insights with scalable data science, analytics, and biometrics expertise from Aixial Group

Overview of Aixial Group’s in-depth experience in the areas of First-In- Human and early phase oncology trials, and why it’s so important to have the most experienced partner by your side when there’s a lot at stake.

Learn how to choose the right Data & Analytics CRO partner with key considerations around data quality, scalability, technology, and team expertise.

Discover expert medical writing solutions for regulatory documents, scientific publications, and clinical trial documentation that ensure quality and compliance.